Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells
Lists
Only you see this
Abstract
Clear-cell renal cell carcinoma (ccRCC), the most common subtype of renal cancer, has a poor clinical outcome. A hallmark of ccRCC is genetic loss-of-function of <i>VHL</i> (von Hippel-Lindau) that leads to a highly vascularized tumor microenvironment. Although many ccRCC patients initially respond to antiangiogenic therapies, virtually all develop progressive, drug-refractory disease. Given the role of dysregulated expressions of cytoskeletal and cytoskeleton-regulatory proteins in tumor progression, we performed analyses of The Cancer Genome Atlas (TCGA) transcriptome data for different classes of actin-binding proteins to demonstrate that increased mRNA expression of profilin1 (Pfn1), Arp3, cofilin1, Ena/VASP, and CapZ, is an indicator of poor prognosis in ccRCC. Focusing further on Pfn1, we performed immunohistochemistry-based classification of Pfn1 staining in tissue microarrays, which indicated Pfn1 positivity in both tumor and stromal cells; however, the vast majority of ccRCC tumors tend to be Pfn1-positive selectively in stromal cells only. This finding is further supported by evidence for dramatic transcriptional up-regulation of Pfn1 in tumor-associated vascular endothelial cells in the clinical specimens of ccRCC. <i>In vitro</i> studies support the importance of Pfn1 in proliferation and migration of RCC cells and in soluble Pfn1's involvement in vascular endothelial cell tumor cell cross-talk. Furthermore, proof-of-concept studies demonstrate that treatment with a novel computationally designed Pfn1-actin interaction inhibitor identified herein reduces proliferation and migration of RCC cells <i>in vitro</i> and RCC tumor growth <i>in vivo</i> Based on these findings, we propose a potentiating role for Pfn1 in promoting tumor cell aggressiveness in the setting of ccRCC.
BibTeX
@article{allen2020actin,
author = {Abigail Allen and David Gau and Paul Francoeur and Jordan Sturm and Yue Wang and Ryan J. Martin and Jodi K. Maranchie and Anette Duensing and Adam Kaczorowski and Stefan Duensing and Lily Wu and Michael T. Lotze and David Ryan Koes and Walter J. Storkus and Partha Roy},
title = {{Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells}},
journal = {Journal of Biological Chemistry},
year = {2020},
doi = {10.1074/jbc.ra120.013963},
}Loading related content...